Glenn Gregory M
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Glenn Gregory M. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| NVAX | President, R&D | Purchase | 2,000 | $7.04 | $14,080 | Mar 6, 2023 |
| NVAX | President, R&D | Option Exercise | 3,100 | — | — | Dec 14, 2022 |
| NVAX | President, R&D | Sale | 213 | $170.46 | $36,308 | Dec 15, 2021 |
| NVAX | President, R&D | Sale | 100 | $182.96 | $18,296 | Dec 7, 2021 |
| NVAX | President, R&D | Sale | 353 | $207.19 | $73,138 | Nov 30, 2021 |
| NVAX | President, R&D | Option Exercise | 2,083 | $5.95 | $12,394 | Nov 26, 2021 |
| NVAX | President, R&D | Sale | 1,400 | $197.44 | $276,416 | Nov 23, 2021 |
| NVAX | President, R&D | Option Exercise | 521 | $27.60 | $14,380 | Nov 16, 2021 |
| NVAX | President, R&D | Option Exercise | 8,250 | $19.08 | $157,410 | Nov 9, 2021 |
| NVAX | President, R&D | Sale | 300 | $187.26 | $56,178 | Nov 2, 2021 |
| NVAX | President, R&D | Sale | 39 | $145.41 | $5,671 | Oct 29, 2021 |
| NVAX | President, R&D | Option Exercise | 2,084 | $5.95 | $12,400 | Oct 26, 2021 |
| NVAX | President, R&D | Sale | 100 | $172.03 | $17,203 | Oct 19, 2021 |
| NVAX | President, R&D | Option Exercise | 662 | $46.00 | $30,452 | Oct 15, 2021 |
| NVAX | President, R&D | Sale | 800 | $164.50 | $131,600 | Oct 12, 2021 |
| NVAX | President, R&D | Sale | 700 | $172.70 | $120,890 | Oct 5, 2021 |
| NVAX | President, R&D | Sale | 55 | $203.94 | $11,217 | Sep 30, 2021 |
| NVAX | President, R&D | Sale | 203 | $235.10 | $47,725 | Sep 27, 2021 |
| NVAX | President, R&D | Sale | 65 | $233.02 | $15,146 | Sep 15, 2021 |
| NVAX | President, R&D | Sale | 359 | $239.66 | $86,038 | Aug 31, 2021 |
| NVAX | President, R&D | Sale | 100 | $227.74 | $22,774 | Aug 26, 2021 |
| NVAX | President, R&D | Sale | 204 | $231.27 | $47,179 | Aug 16, 2021 |
| NVAX | President, R&D | Sale | 199 | $202.76 | $40,349 | Jul 20, 2021 |
| NVAX | President, R&D | Option Exercise | 870 | $27.60 | $24,012 | Jul 15, 2021 |
| NVAX | President, R&D | Sale | 200 | $198.39 | $39,678 | Jun 15, 2021 |
| NVAX | President, R&D | Sale | 162 | $144.36 | $23,386 | May 19, 2021 |
| NVAX | President, R&D | Sale | 417 | $216.11 | $90,118 | Apr 19, 2021 |
| NVAX | President, R&D | Sale | 402 | $217.31 | $87,359 | Mar 15, 2021 |
| NVAX | President, R&D | Sale | 65 | $278.27 | $18,088 | Feb 18, 2021 |
| NVAX | President, R&D | Sale | 413 | $291.57 | $120,418 | Feb 16, 2021 |
| NVAX | President, R&D | Sale | 6,661 | $109.07 | $726,559 | Sep 28, 2020 |
| NVAX | President, R&D | Option Exercise | 38,588 | — | — | Sep 26, 2020 |
| NVAX | President, R&D | Option Exercise | 16,658 | $27.60 | $459,761 | Aug 18, 2020 |
| NVAX | President, R&D | Sale | 16,749 | $59.53 | $997,068 | Jun 18, 2020 |
| NVAX | President, R&D | Tax Withholding | 294 | $12.48 | $3,669 | Mar 8, 2020 |
| NVAX | President, R&D | Purchase | 1,250 | $3.86 | $4,825 | Jan 31, 2020 |
| NVAX | President, R&D | Sale | 9,620 | $6.18 | $59,452 | Sep 13, 2019 |
| NVAX | President, R&D | Option Exercise | 7,608 | — | — | Sep 8, 2019 |
| NVAX | President, R&D | Purchase | 1,000 | $5.85 | $5,850 | May 13, 2019 |
| NVAX | President, R&D | Purchase | 13,168 | $0.88 | $11,588 | Jan 31, 2019 |
| NVAX | President, R&D | Purchase | 13,007 | $0.88 | $11,446 | Jul 31, 2018 |
| NVAX | President, R&D | Purchase | 100 | $1.64 | $164 | May 14, 2018 |
| NVAX | President, R&D | Purchase | 12,784 | $0.88 | $11,250 | Jan 31, 2018 |
| NVAX | President, R&D | Purchase | 10,000 | $1.13 | $11,300 | Nov 9, 2017 |
| NVAX | President, R&D | Purchase | 1,000 | $1.45 | $1,450 | Dec 7, 2016 |
| NVAX | President, R&D | Purchase | 1,000 | $1.65 | $1,650 | Sep 21, 2016 |
| NVAX | SVP, Research and Development | Purchase | 2,369 | $4.38 | $10,376 | Jan 31, 2016 |
| NVAX | SVP, Research and Development | Sale | 61,886 | $8.58 | $530,982 | Dec 16, 2015 |
| NVAX | SVP, Research and Development | Gift | 1,100 | — | — | Aug 24, 2015 |
| NVAX | SVP, Research and Development | Option Exercise | 15,000 | $2.11 | $31,650 | Aug 18, 2015 |